According to the research report titled ‘North America Joint Reconstruction Devices Market Forecast 2027 By Joint Type, Research Report, Country Outlook, COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share,’ available with MarketStudyReport, North America joint reconstruction devices market is slated to amass USD 12 billion in revenue during 2021-2027.

Soaring geriatric population, increase in joint reconstruction surgeries, surging prevalence of orthopedic diseases, and massive investments employed by leading players for new & innovative procedures are factors driving North America joint reconstruction devices industry expansion.

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/4485031/

Also, the increase in cases of musculoskeletal disorders like back pain, arthritis, etc., which call for quick medical care as they hinder a person’s quality of life as well as considerable support from government in ways of regulatory approvals for enhanced services are furthering the scope of business sphere. 

Moreover, collaborations among industry players by ways of strategic mergers is leading to a surge in product uptake during the review period. 

Despite the positive outlook, dearly costs of devices, biocompatibility issues, and post-surgery complications are variables likely to hinder the progress of market in the forthcoming years. 

In terms of joint type, the hip replacement vertical of North America joint reconstruction devices market is anticipated to accrue nearly USD 4,247 million by 2027, owing to the high prevalence of hip osteoarthritis which mandates supportive therapeutics, frequent follow-ups, and surgical therapy. 

Concerning the geographical aspect, the U.S. market was valued at USD 7,976 million in 2020 and is poised to record significant growth during the assessment timeframe, attributed to the proliferation of developed technologies in healthcare vertical. 

Meanwhile, Canada industry is expected to expand at 4.7% CAGR during the speculated timeline, ascribed to the rising cases of musculoskeletal injuries, surging incidences of degenerative arthritis, and a huge elderly population base. 

The notable players in North America joint reconstruction devices marketplace include names like Smith & Nephew plc, Stryker Corporation, Microport Scientific Corporation, aap Implantate AG, Lima Corporate, B. Braun Melsungen AG, Johnson & Johnson, Alphatec Holdings Inc., Integra LifeSciences Holdings Corporation, Arthrex Inc., Globus Medical Inc., ConforMIS Inc., Exactech, CONMED Corporation, and DJO Global among others.